[Form 4] MetLife, Inc. Insider Trading Activity
Robert Glenn Hubbard, a director of MetLife, Inc. (MET), reported an acquisition on 09/09/2025 of 663 shares of MetLife common stock at a price of $79.29 per share. The filing shows the shares were credited through imputed reinvestment of dividends under the MetLife Deferred Compensation Plan for Non-Management Directors, meaning dividend payments that became payable were deferred and converted into additional deferred shares. After this transaction the reporting person beneficially owns 101,151 shares. The Form 4 was filed as a single reporting person filing and signed by an attorney-in-fact on 09/11/2025.
Robert Glenn Hubbard, un direttore di MetLife, Inc. (MET), ha riferito un'acquisizione il 09/09/2025 di 663 azioni ordinarie MetLife al prezzo di $79.29 per azione. La dichiarazione mostra che le azioni sono state accreditate tramite reinvetimento imputato dei dividendi ai sensi del MetLife Deferred Compensation Plan for Non-Management Directors, ovvero i pagamenti di dividendi che diventavano esigibili sono stati differiti e convertiti in ulteriori azioni differite. Dopo questa transazione la persona reportante possiede 101,151 azioni. Il Form 4 è stato presentato come unica persona reportante e firmato da un attorney-in-fact il 09/11/2025.
Robert Glenn Hubbard, un director de MetLife, Inc. (MET), informó una adquisición el 09/09/2025 de 663 acciones comunes de MetLife a un precio de $79.29 por acción. La solicitud indica que las acciones se acreditaron mediante reinversión imputada de dividendos conforme al MetLife Deferred Compensation Plan for Non-Management Directors, es decir, los pagos de dividendos que se hacían exigibles fueron diferidos y convertidos en acciones diferidas adicionales. Tras esta transacción, la persona reportante posee beneficiosamente 101,151 acciones. El Formulario 4 fue presentado como la presentación de una sola persona reportante y firmado por un apoderado el 11/09/2025.
로버트 글렌 허버드는 MetLife, Inc. (MET)의 이사로 09/09/2025에 MetLife 보통주 663주를 주당 $79.29에 취득했다고 보고했습니다. 공시는 주식이 배당금의 내재 재투자(imputed reinvestment of dividends)를 통해 공제되었으며, 이는 비관리 이사용 MetLife 연금 보상 계획에 따라 이익 배당금이 이연되고 추가 이연 주로 전환되었음을 의미합니다. 이 거래 후 보고자는 101,151주를 실제로 보유합니다. Form 4는 단일 보고자 제출로 작성되었고 2025년 9월 11일에 대리인에 의해 서명되었습니다.
Robert Glenn Hubbard, un administrateur de MetLife, Inc. (MET), a signalé une acquisition le 09/09/2025 de 663 actions ordinaires MetLife au prix de 79,29 USD par action. Le dépôt indique que les actions ont été créditées par le réinvestissement imputé des dividendes conformément au MetLife Deferred Compensation Plan for Non-Management Directors, ce qui signifie que les paiements de dividendes devenus exigibles ont été différés et convertis en actions différées supplémentaires. Après cette transaction, la personne déclarant possède bénéficiellement 101 151 actions. Le Formulaire 4 a été déposé par une seule personne déclarant et signé par un mandataire le 11/09/2025.
Robert Glenn Hubbard, ein Direktor von MetLife, Inc. (MET), meldete am 09.09.2025 einen Erwerb von 663 MetLife-Stammaktien zum Preis von 79,29 USD je Aktie. Die Einreichung zeigt, dass die Aktien durch imputierten Dividenden-Reinvestment gemäß dem MetLife Deferred Compensation Plan for Non-Management Directors gutgeschrieben wurden, was bedeutet, dass fällige Dividendenzahlungen aufgeschoben und in zusätzliche verzögerte Anteile umgewandelt wurden. Nach dieser Transaktion besitzt die meldende Person rechtlich 101.151 Aktien. Das Formular 4 wurde als Einzelmeldung von einer meldenden Person eingereicht und am 11.09.2025 von einem Bevollmächtigten unterzeichnet.
روبرت غلن هابارد، مدير في MetLife, Inc. (MET)، قد أبلغ عن استحواذ في 09/09/2025 على 663 سهماً من أسهم MetLife العادية بسعر $79.29 للسهم الواحد. تُظهر الوثيقة أن الأسهم أُضيفت عبر إعادة استثمار مقسَّطة للأرباح وفقاً لخطة MetLife Deferred Compensation Plan for Non-Management Directors، وهذا يعني أن مدفوعات الأرباح التي أصبحت قابلة للدفع تم تأجيلها وتحويلها إلى أسهم مؤجلة إضافية. بعد هذه الصفقة يمتلك الشخص المبلّغ عنه فائدةً 101,151 سهماً. تم تقديم النموذج 4 كإبلاغ من شخص واحد موقع بواسطة وكيل قانوني في 11/09/2025.
Robert Glenn Hubbard，MetLife, Inc.（MET）的董事，报告于 2025年9月9日以每股 $79.29 美元的价格购买了 663 股 MetLife 普通股。申报显示这些股份通过 MetLife 非管理董事延期薪酬计划下的 股息再投资（imputed reinvestment of dividends） 记入，也就是说应付的股息被递延并转换为额外的递延股。交易完成后，申报人实际持有 101,151 股。Form 4 作为单独的申报人提交，并于 2025-09-11 由代理人签署。
- Director ownership increased by 663 shares to a total of 101,151 shares following the reinvestment
- Transaction disclosed timely on Form 4 and executed through an established deferred compensation plan
- None.
Insights
TL;DR: Routine director dividend reinvestment modestly increased insider ownership; not a material change.
The reported transaction is a common, non-discretionary imputed dividend reinvestment under MetLife’s deferred compensation arrangements for non-management directors. Such reinvestments convert payable shares into further deferred shares and do not reflect open-market purchases or sales. The incremental addition of 663 shares represents a small change relative to the reported post-transaction holding of 101,151 shares and is consistent with compensation plan mechanics rather than a deliberate trading decision by the director.
TL;DR: Acquisition via dividend reinvestment increases insider stake slightly; transaction type limits interpretive weight.
The Form 4 discloses an acquisition at $79.29 per share through imputed reinvestment of dividends, not a market purchase. While insider holdings rose to 101,151 shares, the absolute change of 663 shares is immaterial for valuation or control analysis. The disclosure is timely and complies with Section 16 reporting requirements; investors should note the mechanics but not infer an active trading signal from this filing alone.
Robert Glenn Hubbard, un direttore di MetLife, Inc. (MET), ha riferito un'acquisizione il 09/09/2025 di 663 azioni ordinarie MetLife al prezzo di $79.29 per azione. La dichiarazione mostra che le azioni sono state accreditate tramite reinvetimento imputato dei dividendi ai sensi del MetLife Deferred Compensation Plan for Non-Management Directors, ovvero i pagamenti di dividendi che diventavano esigibili sono stati differiti e convertiti in ulteriori azioni differite. Dopo questa transazione la persona reportante possiede 101,151 azioni. Il Form 4 è stato presentato come unica persona reportante e firmato da un attorney-in-fact il 09/11/2025.
Robert Glenn Hubbard, un director de MetLife, Inc. (MET), informó una adquisición el 09/09/2025 de 663 acciones comunes de MetLife a un precio de $79.29 por acción. La solicitud indica que las acciones se acreditaron mediante reinversión imputada de dividendos conforme al MetLife Deferred Compensation Plan for Non-Management Directors, es decir, los pagos de dividendos que se hacían exigibles fueron diferidos y convertidos en acciones diferidas adicionales. Tras esta transacción, la persona reportante posee beneficiosamente 101,151 acciones. El Formulario 4 fue presentado como la presentación de una sola persona reportante y firmado por un apoderado el 11/09/2025.
로버트 글렌 허버드는 MetLife, Inc. (MET)의 이사로 09/09/2025에 MetLife 보통주 663주를 주당 $79.29에 취득했다고 보고했습니다. 공시는 주식이 배당금의 내재 재투자(imputed reinvestment of dividends)를 통해 공제되었으며, 이는 비관리 이사용 MetLife 연금 보상 계획에 따라 이익 배당금이 이연되고 추가 이연 주로 전환되었음을 의미합니다. 이 거래 후 보고자는 101,151주를 실제로 보유합니다. Form 4는 단일 보고자 제출로 작성되었고 2025년 9월 11일에 대리인에 의해 서명되었습니다.
Robert Glenn Hubbard, un administrateur de MetLife, Inc. (MET), a signalé une acquisition le 09/09/2025 de 663 actions ordinaires MetLife au prix de 79,29 USD par action. Le dépôt indique que les actions ont été créditées par le réinvestissement imputé des dividendes conformément au MetLife Deferred Compensation Plan for Non-Management Directors, ce qui signifie que les paiements de dividendes devenus exigibles ont été différés et convertis en actions différées supplémentaires. Après cette transaction, la personne déclarant possède bénéficiellement 101 151 actions. Le Formulaire 4 a été déposé par une seule personne déclarant et signé par un mandataire le 11/09/2025.
Robert Glenn Hubbard, ein Direktor von MetLife, Inc. (MET), meldete am 09.09.2025 einen Erwerb von 663 MetLife-Stammaktien zum Preis von 79,29 USD je Aktie. Die Einreichung zeigt, dass die Aktien durch imputierten Dividenden-Reinvestment gemäß dem MetLife Deferred Compensation Plan for Non-Management Directors gutgeschrieben wurden, was bedeutet, dass fällige Dividendenzahlungen aufgeschoben und in zusätzliche verzögerte Anteile umgewandelt wurden. Nach dieser Transaktion besitzt die meldende Person rechtlich 101.151 Aktien. Das Formular 4 wurde als Einzelmeldung von einer meldenden Person eingereicht und am 11.09.2025 von einem Bevollmächtigten unterzeichnet.
FAQ
What did Robert Glenn Hubbard report on Form 4 for MET?
Was the transaction a market purchase or a dividend reinvestment?
Does this Form 4 indicate a material change in insider ownership of MET?
When was the Form 4 signed and filed?
